(NYSE: AVNS) Avanos Medical's forecast annual revenue growth rate of 0.55% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.
Avanos Medical's revenue in 2025 is $689,200,000.On average, 1 Wall Street analysts forecast AVNS's revenue for 2025 to be $31,313,648,617, with the lowest AVNS revenue forecast at $31,313,648,617, and the highest AVNS revenue forecast at $31,313,648,617. On average, 1 Wall Street analysts forecast AVNS's revenue for 2026 to be $32,222,805,264, with the lowest AVNS revenue forecast at $32,222,805,264, and the highest AVNS revenue forecast at $32,222,805,264.
In 2027, AVNS is forecast to generate $33,123,175,555 in revenue, with the lowest revenue forecast at $33,123,175,555 and the highest revenue forecast at $33,123,175,555.